News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medinol Ltd. Goes After Johnson & Johnson (JNJ)'s Cordis Corporation (JNJ) in Stent Patent War


8/28/2013 7:55:07 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Medinol, which wrung a $750 million patent infringement decision from Boston Scientific in 2005, sues Johnson & Johnson's Cordis stent making arm. Cordis Corp., the stent-making arm of Johnson & Johnson (NYSE:JNJ), got out of the coronary stent game 2 years go, but that's not stopping Israeli medical device company Medinol from suing Cordis for patent infringement with the Cypher and Cypher Select stents it no longer makes. Medinol, which won a $750 million decision over erstwhile partner Boston Scientific (NYSE:BSX) in 2005, accused Cordis in March of violating 4 of its patents with the Cypher stents, according to court documents and regulatory filings.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES